780 Results

People

  1. O'Reilly
    O'Reilly
  2. Abou-Alfa
    Abou-Alfa
  3. Yu
    Yu
  4. Kelsen
    Kelsen
  5. Lowery
    Lowery
  6. Jarnagin
    Jarnagin
  7. Capanu
    Capanu
  8. Saltz
    Saltz
  9. Park
    Park
  10. Chou
    Chou

Groups

  1. Center for Pancreatic Cancer Research (780)
  2. Department of Medicine (780)
  3. Gastrointestinal Oncology Service (780)
  4. Solid Tumor Oncology Division (780)
  5. Epidemiology and Biostatistics (176)
  6. Surgery (166)
  7. Biostatistics Service (152)
  8. Department of Pathology and Laboratory Medicine (152)
  9. GSK Faculty (141)
  10. Survivorship Research (129)
  1. "Eileen O'Reilly"
Formats
  1. Meeting Abstract (361)
  2. Journal Article (354)
  3. Review (23)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (7)
  7. Conference Paper (5)
  8. Book Whole (4)
  9. Miscellaneous (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (780)
  2. Department of Medicine (780)
  3. Gastrointestinal Oncology Service (780)
  4. Solid Tumor Oncology Division (780)
  5. Epidemiology and Biostatistics (176)
  6. Surgery (166)

More Groups

People
  1. Eileen O'Reilly (780)
  2. Ghassan Abou-Alfa (155)
  3. Kenneth Yu (120)
  4. David Kelsen (112)
  5. Maeve Lowery (99)
  6. Marinela Capanu (93)

More People

Years
  1. 2025 (28)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (290)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (24)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (301)
  2. Oxford University Press (70)
  3. Elsevier Inc. (48)
  4. Springer (45)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (780)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longitudinal imaging markers for pancreas cancer tumor response via Eshelby biomechanics
    Conference Paper

    Heiselman, J. S.; Horvat, N.; El Homsi, M.; Ecker, B. L.; O'Reilly, E. M.; Kingham, T. P.; Soares, K. C.; D'Angelica, M. I.; Jarnagin, W. R.; Do, R. K. G.; more...
    SPIE (2025)

    Fulltext@MSK | Save
  • Neratinib alone or in combination with immune checkpoint inhibitors with or without mammalian target of rapamycin inhibitors in patients with fibrolamellar carcinoma
    Journal Article

    Abou-Alfa, G. K.; Meyer, T.; Do, R. K. G.; Piha-Paul, S. A.; Light, J. S.; Sherrin, S.; Yaqubie, A.; O'Neill, A. C.; Harding, J. J.; Al-Rajabi, R.; more...
    Liver Cancer (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Survival of patients with resected microsatellite instability-high, mismatch repair deficient, and lynch syndrome-associated pancreatic ductal adenocarcinomas
    Miscellaneous

    Eikenboom, E. L.; Nasar, N.; Seier, K.; Gönen, M.; Spaander, M. C. W.; O'Reilly, E. M.; Jarnagin, W. R.; Drebin, J.; D'Angelica, M. I.; Kingham, T. P.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3)
    Editorial

    Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R.; Chandana, S. R.; De La Fouchardière, C.; Dean, A.; Kiss, I.; Jin Leei, W.; Goetze, T. O.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Survival of patients with resected microsatellite instability-high, mismatch repair deficient, and Lynch syndrome-associated pancreatic ductal adenocarcinomas
    Journal Article

    Eikenboom, E. L.; Nasar, N.; Seier, K.; Gönen, M.; Spaander, M. C. W.; O’Reilly, E. M.; Jarnagin, W. R.; Drebin, J.; D’Angelica, M. I.; Kingham, T. P.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Adjuvant cytotoxic chemotherapy may not be associated with a survival advantage for resected intrahepatic cholangiocarcinoma
    Journal Article

    Sharib, J.; Rhodin, K. E.; Liu, A.; McIntyre, S.; Bartholomew, A.; Masoud, S.; DeLaura, I.; Kemeny, N. E.; Cercek, A.; Harding, J. J.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort
    Journal Article

    Keane, F.; O’Connor, C.; Moss, D.; Chou, J. F.; Perry, M. A.; Crowley, F.; Saxena, P.; Chan, A.; Schoenfeld, J. D.; Singhal, A.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2
    Journal Article

    Lucotti, S.; Ogitani, Y.; Kenific, C. M.; Geri, J.; Kim, Y. H.; Gu, J.; Balaji, U.; Bojmar, L.; Shaashua, L.; Song, Y.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Adjuvant cytotoxic chemotherapy may not be associated with a survival advantage for resected intrahepatic cholangiocarcinoma
    Miscellaneous

    Sharib, J.; Rhodin, K. E.; Liu, A.; McIntyre, S.; Bartholomew, A.; Masoud, S.; DeLaura, I.; Kemeny, N. E.; Cercek, A.; Harding, J. J.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save